| Dr Kathryn Stecklein, PHARMD | |
|
929 N Saint Francis St, Wichita, KS 67214-3821 | |
| (316) 268-5722 | |
| Not Available |
| Full Name | Dr Kathryn Stecklein |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 929 N Saint Francis St, Wichita, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053775577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-16747 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathryn Stecklein, PHARMD 929 N Saint Francis St, Wichita, KS 67214-3821 Ph: () - | Dr Kathryn Stecklein, PHARMD 929 N Saint Francis St, Wichita, KS 67214-3821 Ph: (316) 268-5722 |
News Archive
The U.S. Food and Drug Administration (FDA), today issued public health advice, patient information, and professional healthcare information on the risks and benefits of Crestor (Rosuvastatin calcium), a cholesterol-lowering drug.
An intestinal patch device containing insulin that can be swallowed in the form of a capsule, in development by researchers at University of California Santa Barbara, has demonstrated efficacy of blood glucose management in diabetic rats. This work is being presented Oct. 27 at the 2015 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Orlando, Fla. Oct. 25-29.
The implementation of personalized health care in cancer relies on the identification and characterization of cancer biomarkers and the availability of accurate detection systems and therapies for those biomarkers.
Bipolar disorder affects millions of Americans, causing dramatic swings in mood and, in some people, additional effects such as memory problems.
By employing an immunoinformatics approach, a new study available on the preprint server bioRxiv* shows how the combination of peptides designed from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid phosphoprotein and spike glycoprotein may trigger an improved immunological response with respectable safety profile, informing, in turn, further vaccine development.
› Verified 6 days ago
Jennifer Howard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 S Clifton Ave, Suite 100, Wichita, KS 67218 Phone: 316-689-6100 | |
Dr. Gage Gregory Swanson, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1402 S Ridge Road, Wichita, KS 67209 Phone: 316-945-7455 Fax: 316-945-7457 | |
Yvonne Elias-moussa, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 N Saint Francis Ave Ste 130, Wichita, KS 67214 Phone: 316-264-3505 Fax: 316-264-0978 | |
Dr. Jacob Arthur Doeden, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3707 N Woodlawn Blvd, Wichita, KS 67220 Phone: 316-691-9134 Fax: 316-691-9138 | |
Dr. Terry Bontrager, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3601 N Webb Rd, Wichita, KS 67226 Phone: 316-630-5350 Fax: 316-630-6349 | |
Jill Baalmann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3311 E Murdock St, Wichita, KS 67208 Phone: 316-274-8280 | |
Cindy L Leddy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5500 E Kellogg Dr, Wichita, KS 67218 Phone: 316-685-2221 |